NCT02579590View on ClinicalTrials.gov

The Female Sexual Functions With Progestogen-only Contraception

CompletedOBSERVATIONAL
Enrollment

444

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

February 1, 2019

Study Completion Date

February 1, 2019

Conditions
Female Sexual Function
Interventions
DRUG

Depot Medroxyprogesterone Acetate 150 mg

"the DMPA user where they are using Depot Medroxyprogesterone Acetate 150 mg (DMPA; Phrmcia) injection every 3 month"

DRUG

Implanon( 68 mg etonogestrel implant)

where they are using etonogestrel 68 mg implant (Implanon; Organon)

DRUG

Cerazette pills (75 micrograms desogestrel)

where they are using desogestrel 75 micrograms (Cerazette; Organon), one pill every day for 28 days without pill-free interval.

Trial Locations (1)

71111

Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02579590 - The Female Sexual Functions With Progestogen-only Contraception | Biotech Hunter | Biotech Hunter